Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL

被引：0
|
作者：
Cheung, MC [1 ]
Zhao, XQ [1 ]
Davis, JW [1 ]
Albers, JJ [1 ]
Chait, A [1 ]
Brown, BG [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
CIRCULATION | 1998年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2375
引用
收藏
页码：452 / 452
页数：1
相关论文
共 50 条
  • [21] Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C
    Miller, M
    Dobs, A
    Yuan, Z
    Battisti, WP
    Borisute, H
    Palmisano, J
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (07) : 1087 - 1094
  • [22] Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study design
    Brown, BG
    Zhao, XQ
    Chait, A
    Frohlich, J
    Cheung, M
    Heise, N
    Dowdy, A
    DeAngelis, D
    Fisher, LD
    Albers, J
    CANADIAN JOURNAL OF CARDIOLOGY, 1998, 14 : 6A - 13A
  • [23] LDL-C/HDL-C ratio in patients with coronary artery disease and low HDL-C: The radar study
    Jukema, J
    Liem, A
    Dunselman, P
    van der Sloot, J
    Lok, D
    Zwinderman, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 125 - 126
  • [24] HDL3: A MARKER OF CORONARY ARTERY DISEASE SEVERITY AND INFLAMMATION IN PATIENTS ON STATIN THERAPY
    Gurbel, Paul A.
    Chaudhary, Rahul
    Bliden, Kevin P.
    Toth, Peter
    Tantry, Udaya
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 149 - 149
  • [25] Therapeutic Targets to Raise HDL in Patients at Risk or with Coronary Artery Disease
    Luescher, Thomas F.
    von Eckardstein, Arnold
    Simic, Branko
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (06) : 720 - 724
  • [26] The increased contribution of oxidized LDL to coronary atherosclerosis among patients with premature coronary artery disease and low HDL
    Triantafyllou, K. A.
    Dasopoulou, C.
    Symeonides, P.
    Aggelidou, D.
    El Ali, M.
    Theodoridis, T.
    Papapanagiotou, A.
    Nounopoulos, C.
    Kalofoutis, A.
    Koulouris, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 88 - 88
  • [27] LOW HDL CHOLESTEROL IS NOT ASSOCIATED WITH CORONARY-ARTERY DISEASE IN AZOTEMIC DIABETICS
    MANSKE, CL
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 280 - 280
  • [28] HDL2, HDL3, and MCP-1 Levels in Patients with Premature Coronary Artery Disease
    Sun, Runlu
    Lu, Weifeng
    Zhang, Shumei
    Bao, Jinlan
    Huang, Canxia
    Zhang, Bo
    Lin, Ruiting
    Zhang, Yuling
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C80 - C80
  • [29] HDL3-C is a Marker of Coronary Artery Disease Severity and Inflammation in Patients on Statin Therapy
    Chaudhary, Rahul
    Kinderyte, Marija
    Chaudhary, Rohit
    Sukhi, Ajaypaul
    Bliden, Kevin
    Tantry, Udaya
    Gurbel, Paul
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2019, 20 (11) : 1001 - 1006
  • [30] Lipid transfer to HDL, CETP and HDL composition in coronary artery disease patients with or without type 2 diabetes mellitus
    Tavoni, Thauany M.
    Sprandel, Marilia C. O.
    Laverdy, Oscar G.
    Strunz, Celia M. C.
    Ramires, Jose A. F.
    Kalil-Filho, Roberto
    Hueb, Whady A.
    Maranhao, Raul C.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (19) : 2223 - 2225
12345